Regent Pacific Group Limited (RPGLF)

Market Cap	22.72M -15.6%
Revenue (ttm)	363.00K -49.5%
Net Income	-4.71M
EPS	-0.02
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	175
Open	0.0059
Previous Close	0.1250
Day's Range	0.0059 - 0.0059
52-Week Range	0.0007 - 0.4333
Beta	1.19
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 26, 2026

About Regent Pacific Group

Regent Pacific Group Limited, an investment holding company, focuses on healthcare and life sciences sectors in the United States, Europe, and Asia Pacific. The company operates through two segments, Biopharma and Corporate Investment. It is involved in the research, development, manufacturing, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of AI system for the field of biological aging clocks, at the molecular, cellular, tissue, organ, system, physiological, and psycholo...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1991
• Employees: 16
• Stock Exchange: OTCMKTS
• Ticker Symbol: RPGLF

Financial Performance

In 2025, Regent Pacific Group's revenue was $363,000, a decrease of -49.51% compared to the previous year's $719,000. Losses were -$4.71 million, 5.09% more than in 2024.